[PHARMA] YoY Annualized Quarter Result on 30-Sep-2009 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-Nov-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Sep-2009 [#3]
Profit Trend
QoQ- -20.79%
YoY- -9.38%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 1,773,256 1,537,593 1,336,309 1,302,520 1,303,204 1,188,221 1,054,569 9.03%
PBT 132,088 75,757 64,217 71,930 88,137 72,434 37,136 23.52%
Tax -37,856 -21,620 -21,201 -19,116 -30,154 -25,406 -14,190 17.74%
NP 94,232 54,137 43,016 52,814 57,982 47,028 22,945 26.51%
-
NP to SH 92,860 53,620 43,520 51,038 56,322 45,348 21,298 27.78%
-
Tax Rate 28.66% 28.54% 33.01% 26.58% 34.21% 35.07% 38.21% -
Total Cost 1,679,024 1,483,456 1,293,293 1,249,705 1,245,221 1,141,193 1,031,624 8.44%
-
Net Worth 496,623 464,307 424,715 407,610 374,390 335,831 323,006 7.42%
Dividend
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Div 39,227 - 67,041 38,514 25,672 21,390 16,399 15.62%
Div Payout % 42.24% - 154.05% 75.46% 45.58% 47.17% 77.00% -
Equity
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Net Worth 496,623 464,307 424,715 407,610 374,390 335,831 323,006 7.42%
NOSH 117,683 106,983 106,981 106,984 106,968 106,952 106,955 1.60%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin 5.31% 3.52% 3.22% 4.05% 4.45% 3.96% 2.18% -
ROE 18.70% 11.55% 10.25% 12.52% 15.04% 13.50% 6.59% -
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
RPS 1,506.80 1,437.23 1,249.11 1,217.49 1,218.30 1,110.98 985.99 7.31%
EPS 78.91 50.12 40.68 47.71 52.65 42.40 19.91 25.77%
DPS 33.33 0.00 62.67 36.00 24.00 20.00 15.33 13.80%
NAPS 4.22 4.34 3.97 3.81 3.50 3.14 3.02 5.72%
Adjusted Per Share Value based on latest NOSH - 107,049
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
RPS 123.04 106.69 92.72 90.38 90.42 82.44 73.17 9.03%
EPS 6.44 3.72 3.02 3.54 3.91 3.15 1.48 27.74%
DPS 2.72 0.00 4.65 2.67 1.78 1.48 1.14 15.58%
NAPS 0.3446 0.3222 0.2947 0.2828 0.2598 0.233 0.2241 7.42%
Price Multiplier on Financial Quarter End Date
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Date 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 29/09/06 -
Price 7.55 5.90 4.98 4.09 3.24 3.27 3.98 -
P/RPS 0.50 0.41 0.40 0.34 0.27 0.29 0.40 3.78%
P/EPS 9.57 11.77 12.24 8.57 6.15 7.71 19.99 -11.54%
EY 10.45 8.49 8.17 11.66 16.25 12.97 5.00 13.06%
DY 4.42 0.00 12.58 8.80 7.41 6.12 3.85 2.32%
P/NAPS 1.79 1.36 1.25 1.07 0.93 1.04 1.32 5.20%
Price Multiplier on Announcement Date
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Date 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 13/11/06 -
Price 8.25 5.90 4.92 3.93 3.35 3.42 3.65 -
P/RPS 0.55 0.41 0.39 0.32 0.27 0.31 0.37 6.82%
P/EPS 10.46 11.77 12.09 8.24 6.36 8.07 18.33 -8.91%
EY 9.56 8.49 8.27 12.14 15.72 12.40 5.46 9.77%
DY 4.04 0.00 12.74 9.16 7.16 5.85 4.20 -0.64%
P/NAPS 1.95 1.36 1.24 1.03 0.96 1.09 1.21 8.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment